|
V.RHT.H
|
I'm not bothered about year end targets and the like now. Any sort of...
|
|
V.RHT.H
|
The SP is probably going up either way though, just faster with the...
|
|
V.RHT.H
|
Tim we both know the magic number is .69 TimSanders wrote: They tried to...
|
|
T.TH
|
So do we have to wait until the quarterlies to find this out? SPCEO1...
|
|
V.RHT.H
|
Well if she owns a crystal ball you can't knock her for using it! Get...
|
|
T.TH
|
One journalists take. "As for Cybrexa, its CBX-12 is a peptide-drug...
|
|
T.TH
|
More good science from Kathleen Corey but it's not $$ which is what they...
|
|
V.RHT.H
|
There's already too much speculation here but what do you imagine Q4...
|
|
V.RHT.H
|
The year before it was 8,470,000. In the next quarterly it was explained...
|
|
V.RHT.H
|
I know you just want to hear the perfect scenario but it's just not...
|
|
V.RHT.H
|
Another thing. The omicron wave is an exceptional circumstance. Suddenly, all...
|
|
V.RHT.H
|
So with the recurring revenue model it's hard to explain with an...
|
|
V.RHT.H
|
If you read the regulators documents they want a continuous trading situation...
|
|
V.RHT.H
|
I really, really hope you have money riding on your predictions...
|
|
V.RHT.H
|
Nothing new. Flat Q, blame it on Covid. The promise and hopium shifts to end...
|
|
V.RHT.H
|
lscfa wrote: Missed deadline means regulators will be issuing mgmt cease...
|
|
V.RHT.H
|
Thanks, where did you get the Q breakdown of revenue into software and...
|
|
V.RHT.H
|
While you have your calculator out tell us what revenue they need to hit in...
|
|
T.TH
|
The Immunomedics (Trodelvy) story is worth a read. Certainly didn't smell...
|
|
T.TH
|
I personally don't care that much about the difference between antibodies...
|